161 related articles for article (PubMed ID: 35765089)
21. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
[TBL] [Abstract][Full Text] [Related]
22. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
23. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
[TBL] [Abstract][Full Text] [Related]
24. The homeodomain gene Pitx2 is expressed in primitive hematopoietic stem/progenitor cells but not in their differentiated progeny.
Degar BA; Baskaran N; Hulspas R; Quesenberry PJ; Weissman SM; Forget BG
Exp Hematol; 2001 Jul; 29(7):894-902. PubMed ID: 11438212
[TBL] [Abstract][Full Text] [Related]
25. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
26. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
27. PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5.
Ganga M; Espinoza HM; Cox CJ; Morton L; Hjalt TA; Lee Y; Amendt BA
J Biol Chem; 2003 Jun; 278(25):22437-45. PubMed ID: 12692125
[TBL] [Abstract][Full Text] [Related]
28. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
[TBL] [Abstract][Full Text] [Related]
29. Identification of Biomarkers Associated with Hepatocellular Carcinoma Stem Cell Characteristics Based on Co-Expression Network Analysis of Transcriptome Data and Stemness Index.
Zhao Z; Mu H; Feng S; Liu Y; Zou J; Zhu Y
Crit Rev Eukaryot Gene Expr; 2022; 32(2):47-60. PubMed ID: 35381131
[TBL] [Abstract][Full Text] [Related]
30. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
31. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
Tan HW; Leung CO; Chan KK; Ho DW; Leung MS; Wong CM; Ng IO; Lo RC
Int J Cancer; 2019 Oct; 145(7):1860-1873. PubMed ID: 30834518
[TBL] [Abstract][Full Text] [Related]
32. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
[TBL] [Abstract][Full Text] [Related]
33. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.
Gu Y; Ji F; Liu N; Zhao Y; Wei X; Hu S; Jia W; Wang XW; Budhu A; Ji J; Zhao B; Roessler S; Zheng X; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):268. PubMed ID: 33256802
[TBL] [Abstract][Full Text] [Related]
34. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
35. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.
Zheng Z; Liu J; Yang Z; Wu L; Xie H; Jiang C; Lin B; Chen T; Xing C; Liu Z; Song P; Yin S; Zheng S; Zhou L
Oncotarget; 2016 May; 7(19):28000-12. PubMed ID: 27058905
[TBL] [Abstract][Full Text] [Related]
38. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression.
Zhang Y; Tang B; Song J; Yu S; Li Y; Su H; He S
J Exp Clin Cancer Res; 2019 Feb; 38(1):92. PubMed ID: 30786928
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers.
Lee WK; Thévenod F
Cancer Lett; 2019 May; 449():237-251. PubMed ID: 30742940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
